Citius Provides Update on Its CITI Platforms and Gives Investors Further Insight on their Licensing Agreement with MD Anderson Cancer Center NEW YORK, Feb. 06, 2019 (GLOBE NEWSWIRE) -- Citius Pharmaceuticals, Inc.’s (NASDAQ: CTXR) CEO, Myron Holubiak recently caught up with The Wall Street Analyzer to update investors on the companies’...